Jinjing He

Title: Jinjing He: Innovator in Sigma-2 Receptor Inhibition

Introduction

Jinjing He is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target sigma-2 receptors. His work has implications for therapeutic advancements in treating various diseases.

Latest Patents

Jinjing He holds a patent for an isoindol-sulfilimine compound, which is utilized as a sigma-2 receptor inhibitor. This invention relates to the preparation and application of the compound, which effectively inhibits sigma-2 receptor activity. By binding to the sigma-2 receptor, the compound regulates the receptor complex, leading to the destabilization of adjacent Aβ oligomers at the synapse. This mechanism has potential applications in developing new therapeutic drugs for tumor and neurodegenerative diseases.

Career Highlights

Jinjing He is affiliated with the Shanghai University of Medicine & Health Sciences. His research focuses on innovative approaches to drug development, particularly in the context of neurodegenerative disorders. His work is characterized by a commitment to advancing medical science through innovative chemical solutions.

Collaborations

Jinjing He has collaborated with notable colleagues, including Xiuhong Lu and Gang Huang. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in their respective fields.

Conclusion

Jinjing He is a pioneering inventor whose work on sigma-2 receptor inhibitors holds promise for future therapeutic developments. His contributions to medicinal chemistry are significant and reflect a dedication to improving health outcomes through innovative research.